| abstract |
Compounds that include a structural characteristic of diaryl amine are described herein. Methods for making these compounds, methods for using such compounds in order to modulate the activity of nuclear steroid hormone receptors, and pharmaceutical compositions and medicaments comprising these compounds are also described herein. Methods for using such compounds, pharmaceutical compositions, and medicaments for treating and / or preventing diseases or conditions associated with the activity of nuclear steroid hormone receptors are also described herein. |